Tokyo Tape
Sign in
← SymBio Pharmaceuticals

Annual report

4582.TEDINET S100XNE5
Period2025-01-01 → 2025-12-31
Filed2026-03-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 130
MetricValuePeriodScopeSource row
Revenue¥1.3bn2025-01-01 → 2025-12-31Cons.Net sales
Revenue¥2.5bn2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥5.6bn2023-01-01 → 2023-12-31vCons.Net sales (5-year summary)
Revenue¥10.0bn2022-01-01 → 2022-12-31vCons.Net sales (5-year summary)
Operating income−¥4.4bn2025-01-01 → 2025-12-31Cons.Operating income
Operating income−¥3.9bn2024-01-01 → 2024-12-31Cons.Operating income
Ordinary income−¥4.6bn2025-01-01 → 2025-12-31Cons.Ordinary income
Ordinary income−¥3.7bn2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥736m2023-01-01 → 2023-12-31vCons.Ordinary income loss (5-year summary)
Ordinary income¥2.0bn2022-01-01 → 2022-12-31vCons.Ordinary income loss (5-year summary)
Profit before tax−¥4.7bn2025-01-01 → 2025-12-31Cons.Income before income taxes
Profit before tax−¥3.8bn2024-01-01 → 2024-12-31Cons.Income before income taxes
Net income (owners)−¥4.8bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥2.0bn2023-01-01 → 2023-12-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.2bn2022-01-01 → 2022-12-31vCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥4.8bn2025-01-01 → 2025-12-31Cons.Profit loss
Net income−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss
Total assets¥3.9bnat 2025-12-31Cons.Assets
Total assets¥5.0bnat 2024-12-31Cons.Assets
Total assets¥8.2bnat 2023-12-31vCons.Total assets (5-year summary)
Total assets¥10.4bnat 2022-12-31vCons.Total assets (5-year summary)
Total liabilities¥2.6bnat 2025-12-31Cons.Liabilities
Total liabilities¥771mat 2024-12-31Cons.Liabilities
Net assets / equity¥1.3bnat 2025-12-31Cons.Net assets
Net assets / equity¥4.2bnat 2024-12-31Cons.Net assets
Net assets / equity¥7.2bnat 2023-12-31vCons.Net assets
Net assets / equity¥8.5bnat 2022-12-31vCons.Net assets (5-year summary)
Cash and deposits¥2.9bnat 2025-12-31Cons.Cash and deposits
Cash and deposits¥4.0bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥2.9bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2023-12-31vCons.Cash and cash equivalents
Cash & equivalents¥6.3bnat 2022-12-31vCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥4.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥3.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥195m2023-01-01 → 2023-12-31vCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.6bn2022-01-01 → 2022-12-31vCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥76m2025-01-01 → 2025-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥4m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥377m2023-01-01 → 2023-12-31vCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥47m2022-01-01 → 2022-12-31vCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.6bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥708m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥680m2023-01-01 → 2023-12-31vCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥628m2022-01-01 → 2022-12-31vCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-95.122025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-852024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-49.192023-01-01 → 2023-12-31vCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥30.22022-01-01 → 2022-12-31vCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥29.772022-01-01 → 2022-12-31vCons.Diluted earnings per share (5-year summary)
Net assets per share¥15.54at 2025-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥84.66at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥164.32at 2023-12-31vCons.Net assets per share (5-year summary)
Net assets per share¥204.83at 2022-12-31vCons.Net assets per share (5-year summary)
Equity ratio23.9%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio78.1%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio84.9%at 2023-12-31vCons.Equity to asset ratio (5-year summary)
Equity ratio77.6%at 2022-12-31vCons.Equity to asset ratio (5-year summary)
ROE14.6%2022-01-01 → 2022-12-31vCons.Rate of return on equity (5-year summary)
Employees91at 2025-12-31Cons.Number of employees
Employees108at 2024-12-31Cons.Number of employees
Employees109at 2023-12-31vCons.Number of employees
Employees122at 2022-12-31vCons.Number of employees
Revenue¥1.3bn2025-01-01 → 2025-12-31StandaloneNet sales
Revenue¥2.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.6bn2023-01-01 → 2023-12-31vStandaloneNet sales (5-year summary)
Revenue¥10.0bn2022-01-01 → 2022-12-31vStandaloneNet sales (5-year summary)
Revenue¥8.3bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Operating income−¥4.6bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income−¥4.0bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income−¥4.8bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income−¥3.8bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥774m2023-01-01 → 2023-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥2.0bn2022-01-01 → 2022-12-31vStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.0bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥4.9bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax−¥3.9bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income−¥4.9bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income−¥3.9bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥2.0bn2023-01-01 → 2023-12-31vStandaloneNet income loss (5-year summary)
Net income¥1.2bn2022-01-01 → 2022-12-31vStandaloneNet income loss (5-year summary)
Net income¥2.0bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Total assets¥3.6bnat 2025-12-31StandaloneAssets
Total assets¥4.7bnat 2024-12-31StandaloneAssets
Total assets¥8.2bnat 2023-12-31vStandaloneTotal assets (5-year summary)
Total assets¥10.4bnat 2022-12-31vStandaloneTotal assets (5-year summary)
Total assets¥8.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥2.5bnat 2025-12-31StandaloneLiabilities
Total liabilities¥639mat 2024-12-31StandaloneLiabilities
Net assets / equity¥1.0bnat 2025-12-31StandaloneNet assets
Net assets / equity¥4.1bnat 2024-12-31StandaloneNet assets
Net assets / equity¥7.2bnat 2023-12-31vStandaloneNet assets
Net assets / equity¥8.5bnat 2022-12-31vStandaloneNet assets (5-year summary)
Net assets / equity¥6.7bnat 2021-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.5bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥3.7bnat 2024-12-31StandaloneCash and deposits
Cash & equivalents¥3.9bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥140m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥71m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥72m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-97.622025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-872024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-49.792023-01-01 → 2023-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥30.372022-01-01 → 2022-12-31vStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥53.042021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥29.952022-01-01 → 2022-12-31vStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥52.322021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥11.38at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥82.12at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥164.02at 2023-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥204.95at 2022-12-31vStandaloneNet assets per share (5-year summary)
Net assets per share¥162.26at 2021-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio19.0%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio79.7%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio84.6%at 2023-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio77.8%at 2022-12-31vStandaloneEquity to asset ratio (5-year summary)
Equity ratio73.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE16.6%2022-01-01 → 2022-12-31vStandaloneRate of return on equity (5-year summary)
ROE39.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued59,567,080at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued45,928,856at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued42,278,081at 2023-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued39,603,606at 2022-12-31vStandaloneTotal number of issued shares (5-year summary)
Shares issued38,457,206at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees86at 2025-12-31StandaloneNumber of employees
Employees101at 2024-12-31StandaloneNumber of employees
Employees103at 2023-12-31vStandaloneNumber of employees
Employees118at 2022-12-31vStandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segmentemployeesat 2025-12-3191 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,228
ItemContextValueUnit
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所グロース
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は、100株であります。
Details of employee share option program (text)FilingDateInstantText · Plus
Description of rights plan (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Shareholding by shareholder category (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)吉田　文紀
Address major shareholdersCurrentYearInstant_No1MajorShareholdersMember
Original text (Japanese)東京都港区
Name major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)楽天証券株式会社共有口
Address major shareholdersCurrentYearInstant_No2MajorShareholdersMember
Original text (Japanese)東京都港区南青山２丁目６番21号
Name major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)株式会社SBI証券
Address major shareholdersCurrentYearInstant_No3MajorShareholdersMember
Original text (Japanese)東京都港区六本木１丁目６番１号
Name major shareholdersCurrentYearInstant_No4MajorShareholdersMember
Original text (Japanese)MORGAN STANLEY ＆ CO. LLC（常任代理人　モルガン・スタンレーMUFG証券株式会社）
Address major shareholdersCurrentYearInstant_No4MajorShareholdersMemberText · Plus
Name major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)JPモルガン証券株式会社
Address major shareholdersCurrentYearInstant_No5MajorShareholdersMember
Original text (Japanese)東京都千代田区丸の内２丁目７－３
Name major shareholdersCurrentYearInstant_No6MajorShareholdersMemberText · Plus
Address major shareholdersCurrentYearInstant_No6MajorShareholdersMember
Original text (Japanese)P.O. BOX 351 BOSTON MASSACHUSETTS02101 U.S.A（東京都港区港南２丁目15－１）
Name major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)陳元
Address major shareholdersCurrentYearInstant_No7MajorShareholdersMember
Original text (Japanese)東京都江戸川区
Name major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)村山　信也
Address major shareholdersCurrentYearInstant_No8MajorShareholdersMember
Original text (Japanese)東京都西多摩郡瑞穂町
Name major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)木下　みどり
Address major shareholdersCurrentYearInstant_No9MajorShareholdersMember
Original text (Japanese)千葉県千葉市美浜区
Name major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)日本証券金融株式会社
Address major shareholdersCurrentYearInstant_No10MajorShareholdersMember
Original text (Japanese)東京都中央区日本橋茅場町１丁目２－10号
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentYearInstant_SharesWithNoVotingRightsMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember－
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は、100株であります。
Description issued shares voting rightsCurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember
Original text (Japanese)１単元(100株)未満の株式
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese) シンバイオ製薬株式会社
Address of shareholder treasury shares etcCurrentYearInstant_Row1Member
Original text (Japanese)東京都港区虎ノ門四丁目１番28号
Classes of shares etc (text)FilingDateInstantText · Plus
Acquisitions by resolution of shareholders meeting (text)FilingDateInstantText · Plus
Acquisitions by resolution of board of directors meeting (text)FilingDateInstantText · Plus
Acquisitions not based on resolution of shareholders meeting or board of directors meeting (text)FilingDateInstantText · Plus
Disposals or holding of acquired treasury shares (text)FilingDateInstantText · Plus
Dividend policy (text)FilingDateInstantText · Plus
Overview of corporate governance (text)FilingDateInstantText · Plus
Corporate governance company with audit and supervisory committee (text)FilingDateInstantText · Plus
Information about officers (text)FilingDateInstantText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
balance sheet identitynon_consolidated 2025-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass